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Background:  Bloodstream  infections  (BSIs)  are  the  most  frequent  nosocomial  infections  in
neonatal intensive  care  units  (NICUs),  especially  in  very  low  birth  weight  (VLBW)  infants  (birth
weight ≤  1500  g).  An  epidemiologic  surveillance  system  may  contribute  to  the  prevention  ofinfection;
Intensive  care;
infection  by  continuous  monitoring  of  its  frequency  and  associated  risk  factors.  The  aim  of  this
article was  to  describe  the  implementation  of  the  NeoKissEs  surveillance  system  for  BSIs  in
VLBW newborns  in  a  group  of  Spanish  NICUs.
 Please cite this article as: Madrid-Aguilar M, López-Herrera MC, Pérez-López J, Escudero-Argaluza J, Santesteban-Otazu E, Piening B,
et al. Implementation of NeoKissEs in Spain: A validated surveillance system for nosocomial sepsis in very low birth weight infants. An
Pediatr (Barc). 2019;91:3--12.
∗ Corresponding author.
E-mail address: JOSEIGNACIO.PIJOANZUBIZARRETA@osakidetza.eus (J.I. Pijoán-Zubizarreta).
1 The names of the components of the NeoKissEs group are listed in Appendix 1.
Abbreviations: BSI, bloodstream infection; CABSI, catheter-associated blood stream infection; CRIB, Clinical Risk Index for Babies; NICU,
neonatal intensive care unit; VLBW, very low birth weight.
2341-2879/© 2018 Published by Elsevier España, S.L.U. on behalf of Asociación Española de Pediatŕıa. This is an open access article under
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Very  low  birth  weight
Methods:  We  assessed  the  clinical  cohort  consisting  of  all  VLBW  newborns  aged  less  than  28  days
admitted to  the  participating  units.  In  the  pilot  phase,  2  NICUs  translated  and  adapted  materials
from the  original  German  NEO-KISS  system.  During  implementation,  210  health  care  profes-
sionals attended  one  of  8  educational  workshops.  A  web-based  system  was  created  that  allows
entering data  regarding  patients  and  BSI  episodes,  data  monitoring,  benchmarking  and  providing
feedback to  the  units.  At  each  NICU,  one  neonatologist  was  responsible  for  the  implementation
of the  system  and  reporting  the  difficulties  perceived  throughout  the  process.
Results:  Out  of  the  50  units  that  agreed  to  participate,  45  successfully  started  using  the
surveillance  platform  during  the  implementation  phase,  recording  1108  episodes  of  catheter-
associated  BSI  (CABSI)  in  3638  newborns,  and  finding  an  overall  rate  of  CABSI  of  18.4  (95%  CI,
17.8-19.1) per  1000  catheter  days.
Conclusions:  The  NeoKissEs  surveillance  system  constitutes  a  helpful  source  of  information  for
the purpose  of  benchmarking  the  performance  of  neonatal  units,  assessing  factors  associated
with BSI  in  VLBW  infants  and  measuring  the  impact  of  future  preventive  interventions  in  NICUs.
© 2018  Published  by  Elsevier  España,  S.L.U.  on  behalf  of  Asociación  Española  de  Pediatŕıa.











Muy  bajo  peso
Implementación  de  NeoKissEs  en  España: un  sistema  validado  de  vigilancia  de  la
sepsis  nosocomial  en  recién  nacidos  de  muy  bajo  peso
Resumen
Antecedentes:  Las  sepsis  son  las  infecciones  nosocomiales  más  frecuentes  en  las  Unidades  de
Cuidados Intensivos  Neonatales  (UCIN),  afectando  especialmente  a  los  recién  nacidos  de  muy
bajo peso  al  nacer  (RNMBP,  ≤  1.500  g).  Un  sistema  de  vigilancia  epidemiológica  puede  contribuir
a su  prevención  mediante  una  evaluación  continua  de  su  frecuencia  y  factores  de  riesgo  asoci-
ados. El  objetivo  de  este  artículo  es  describir  la  implementación  del  sistema  de  vigilancia  de
las sepsis  nosocomiales  en  RNMBP  (NeoKissEs)  en  un  grupo  de  UCIN  españolas.
Métodos:  Estudio  de  cohorte  de  RNMBP  con  <  28  días  de  edad  ingresados  en  las  UCIN  par-
ticipantes.  Dos  UCIN  tradujeron  y  adaptaron  materiales  a  partir  del  sistema  original  alemán
NEO-KISS.  Durante  la  implementación,  se  desarrollaron  8  talleres  formativos,  con  participación
de 210  profesionales.  Se  creó  un  sistema  web  para  la  introducción  de  datos  de  pacientes  y
episodios de  sepsis,  su  monitorización,  análisis  comparativo  y  retroalimentación  a  las  unidades.
En cada  UCIN,  un  neonatólogo  fue  responsable  de  la  implementación,  recogiendo  información
sobre las  dificultades  percibidas  durante  el  proceso.
Resultados:  De  50  unidades  que  aceptaron  participar,  45  utilizaron  NeoKissEs  durante  la  fase
de implementación,  registrando  1.108  episodios  de  sepsis  asociados  a  catéter  vascular  en  3.638
neonatos,  con  una  tasa  de  18,4  episodios  por  1.000  pacientes-día  con  catéter  (IC  del  95%:
17,8-19,1).
Conclusiones:  El  sistema  de  vigilancia  epidemiológica  NeoKissEs  representa  una  fuente  útil  de
información  para  la  comparación  estandarizada  de  la  incidencia  de  sepsis  de  las  UCIN,  evaluar
factores de  riesgo  y  facilitar  la  evaluación  del  efecto  de  futuras  intervenciones  preventivas.
© 2018  Publicado  por  Elsevier  España,  S.L.U.  en  nombre  de  Asociación  Española  de  Pediatŕıa.



















ery  low  birth  weight  (VLBW)  infants  (birth  weight  ≤  1500  g)
re  particularly  vulnerable  to  nosocomial  infections.  The
mmaturity  of  their  immune  system,  the  fragility  of  their
kin  and  the  multiple  life  support  procedures  used  in
heir  care  are  among  the  factors  associated  with  the  high
ncidence  of  these  infections  and  the  associated  morbid-
ty  and  mortality.1,2 Bloodstream  infections  (BSIs)  are  the




are  units  (NICUs).  Epidemiologic  surveillance  systems  may
ontribute  to  the  prevention  of  infection  through  the  con-
inuous  assessment  of  its  incidence  and  the  associated  risk
actors.3--5 Such  systems  must  regularly  produce  standard-
sed  indicators  for  self-assessment  of  health  care  quality  and
enchmarking  among  participating  NICUs.6--8 In  addition,  the
mplementation  and  management  of  a  surveillance  system
equires  a  sound  methodology  and  an  effective  organisa-
ional  strategy  to  obtain  accurate  and  reliable  data  on

















European  Neonatology  Network  [EuroNeoNet] between  2006
and  2011).13
Seventy-nine  Spanish  NICUs  of  the  105  registered  withImplementation  of  NeoKissEs:  A  surveillance  system  for  noso
of  newly  introduced  preventive  and  quality  improvement
measures.9,10
In  Europe,  the  German  National  Reference  Center  for
Surveillance  of  Nosocomial  Infections,  which  has  imple-
mented  a  specific  system  for  VLBW  infants  (NEO-KISS),
has  pioneered  the  epidemiological  surveillance  of  BSI.5
A  decrease  in  the  incidence  of  BSI  was  observed  in  the
early  years  of  operation  of  this  system  in  Germany.4
During  this  time,  there  was  no  nationwide  system  for
prospective  data  collection  that  would  have  allowed  Span-
ish  NICUs  to  document  and  track  BSIs  in  VLBW  infants.
This  posed  challenges  to  the  standardised  measurement  of
incidence  rates  and  of  associated  risk  factors,  especially
those  that  are  actually  modifiable  (catheter  and  antibiotic
use).
The  purpose  of  this  article  was  to  describe  our  expe-
rience  in  the  implementation  of  the  Spanish  NeoKissEs
system  for  the  surveillance  of  BSIs  in  VLBW  infants.
NeoKissEs  is  based  on  the  German  NEO-KISS,  whose  def-
initions  and  methodology  have  been  validated  and  are
currently  applied  in  some  of  the  surveillance  proto-
cols  of  the  European  Centre  for  Disease  Prevention  and
Control.11 E
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Figure  1  Recruitment  of  neonatal  intensive  care  units  (NICUs)  elig
a 26  of  the  105  NICUs  that  registered  patients  in  EuroNeoNet  did  not
b 4  NICUs  declined  the  invitation  and  18  did  not  respond.  These  22  NI
their median  number  of  deliveries  per  year  was  lower  compared  to  
smaller (fewer  admissions  and  fewer  both  intensive  and  medium  car
c 2  NICUs  reported  admitting  less  than  15  VLBW  infants  per  year,  1
Committee and  4  did  not  start  implementing  the  system.ial  sepsis  in  VLBW  5
ethods
rotocol  development  and  NICU  recruitment
ruces  University  Hospital  and  forms  used  in  the  German
EO-KISS  system  to  local  needs.5,12 A  coordination  team  of
ealth  care  professionals  in  the  fields  of  neonatology,  pre-
entive  medicine  and  epidemiology  was  established.  Later,
2  de  Octubre  Hospital  Universitario  (Madrid)  joined  the
ilot  phase,  and  the  two  hospitals  collaborated  in  developing
he  full  adapted  surveillance  protocol  in  close  communi-
ation  with  the  staff  of  the  German  NEO-KISS  system.  A
tructured  process  for  the  voluntary  enrolment  of  NICUs
ationwide  was  initiated  in  February  2013  (Figure  1).
The  inclusion  criteria  were:  having  at  least  15  admissions
f  VLBW  infants  annually  and  a  documented  incidence  of
SI  above  the  first  quartile  for  the  reference  population
infants  admitted  to  Spanish  NICUs  that  were  part  of  theuroNeoNet  fulfilled  the  inclusion  criteria  and  were  invited
ase
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but did not start implementationc
n = 7 (8.9%)
NICUs that registered patients 
by 31 December 2015
n = 45
ible  for  implementation  of  the  NeoKissEs  surveillance  system.
 meet  inclusion  criteria.
CUs  were  located  in  9  of  the  17  Spanish  administrative  regions,
participating  NICUs  (1925  vs  2704;  P  =.011),  they  tended  to  be
e  cots)  and  they  provided  less  complex  care.



































































































o  participate  (Figure  1).  All  participating  NICUs  provided
nformation  on  the  size  and  characteristics  of  their  catch-
ent  population  and  their  unit.  This  information  was  used
o  categorise  the  units  based  on  their  level  of  care  accord-
ng  to  the  definitions  of  the  Standards  Committee  of  the
ociedad  Española  de  Neonatología  (Spanish  Society  for
eonatology).14
xtending  the  system  to  other  hospitals
he  NeoKissEs  protocol  was  reviewed  by  all  participating
ospitals  and  evaluated  and  approved  by  their  respective
linical  Research  Ethics  Committees,  which  waived  the  writ-
en  informed  consent  requirement.  Nevertheless,  parents
nd  legal  guardians  were  informed  about  the  surveillance
ystem.
A  neonatologist  was  appointed  in  each  NICU  to  over-
ee  the  implementation  of  NeoKissEs.  These  neonatologist
hampions  participated  in  a  workshop  that  introduced
hem  to  the  protocol,  its  application  and  the  use  of
ssociated  instruments  (manuals,  video  tutorials,  the  elec-
ronic  case  report  form  and  statistical  reports).  All
hese  instruments  were  available  at  the  system’s  web-
ite  (www.neokisses.com),  which  was  created  to  register
atients  and  episodes  of  BSI  and  to  which  only  the  appointed
hampions  had  password-protected  access.
The  coordination  team  recommended  that  the  implemen-
ation  team  in  each  NICU  was  formed  by  at  least  2  staff  from
he  unit:  a  nurse  with  experience  in  neonatal  care  and  a
enior  neonatologist.  One  of  them  would  be  responsible  for
he  daily  collection  of  data  (catheter  and  antibiotic  use),
nd  the  other  with  verifying  the  validity  and  accuracy  of  the
ata  and  the  fulfilment  of  the  NeoKissEs  criteria  for  the  defi-
ition  of  an  episode  of  BSI  before  entering  the  recorded  data
nto  the  system.  The  coordination  team  also  recommended
ntegrating  staff  with  experience  in  infection  control  (usu-
lly  employed  in  preventive  medicine  departments).
In  mid-2014,  a  survey  was  carried  out  among  the  45
ICUs  that  had  initiated  the  implementation  of  NeoKissEs,
sking  about  the  difficulties  experienced  by  the  champions
nd  their  teams  in  the  process,  and  the  strategies  used  to
ddress  them.
ata  collection
he  target  population  of  NeoKissEs  comprises  all  VLBW
nfants  admitted  to  a  participating  NICU  at  age  less  than
8  days,  regardless  of  gestational  age  at  birth.  Every  VLBW
nfant  registered  in  NeoKissEs  was  followed  up  until  dis-
harge  from  the  unit,  transfer  to  another  hospital,  death
r  reaching  of  a  body  weight  of  1800  g,  in  accordance  with
he  NEO-KISS  criteria.
At  NICU  admission,  demographic,  clinical  and  perinatal
ata  are  recorded  in  what  is  called  the  patient  surveillance
aster  data  form  (with  fields  for  birth  weight,  gestational
ge,  date  of  birth  and  of  admission,  type  of  delivery,  sex,
umber  of  foetuses  and  Clinical  Risk  Index  for  Babies  [CRIB]
core).15 When  the  required  fields  are  filled  out,  the  sys-
em  assigns  a  surveillance  code  number  to  the  infant  and
he  form  becomes  an  active  record  in  the  surveillance  pro-
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he  task  (usually  a  nurse)  fills  out  a  paper-based  patient
rogress  chart  every  day,  checking  whether  the  care  of
he  patient  includes  any  of  the  following  interventions:
lacement  of  a  central  or  peripheral  vascular  catheter,  and
ntibiotic  administration.  A  cumulative  summary  is  pro-
uced  for  each  patient  at  the  end  of  each  month.  When
he  period  of  surveillance  ends  for  a  patient,  the  data  from
heir  progress  charts  are  entered  manually  into  the  online
atabase  as  a  cumulative  summary  of  the  data  collected
onthly.  The  facilitator  of  the  NICU  assesses  and  guaran-
ees  the  quality  of  the  comprehensive  data  entered  in  the
ystem.
eoKissEs  outcomes
he  primary  outcome  of  NeoKissEs  is  primary  BSI,  understood
s  BSI  with  onset  at  least  72  hours  after  birth  or  admission
f  an  eligible  infant  to  the  NICU.5,16 The  NeoKissEs  protocol
dheres  strictly  to  the  German  NEO-KISS  definitions  of  BSI,
hich  were  originally  adapted  from  those  of  the  Centers  for
isease  Control  and  Prevention  and  have  been  tested  and
alidated  in  German  NICUs.12,17
When  a facilitator  detects  a  possible  episode  of  primary
SI  (alerted  by  the  staff  managing  the  patient  or  by  the  ini-
iation  of  a  course  of  antibiotic  treatment),  they  open  a  BSI
ata  collection  form,  which  contains  a  checklist  of  the  signs
nd  symptoms  required  for  a  clinically  suspected  BSI  episode
o  qualify  as  a  NeoKissEs  BSI  event.  At  this  point,  the  system
equests  information  about  culture  results,  which  are  used
o  classify  the  current  BSI  episode  as  one  of  the  following:
 Microbiologically-confirmed  BSI  with  coagulase-negative
Staphylococcus  as  the  sole  pathogen.
 Microbiologically-confirmed  BSI  with  detection  of  at  least
one  pathogen  other  than  coagulase-negative  Staphylococ-
cus.
 Clinical  BSI,  with  no  pathogen  isolated  in  culture  but  in
which  the  patient  receives  antimicrobial  treatment  for  at
least  5  days.5
The  online  system  does  not  register  the  episode  into  the
SI  database  unless  all  required  fields  have  been  filled  out,
nd  the  neonatologist  appointed  as  facilitator  has  to  verify
he  accuracy  of  all  BSI-related  data.  The  coordination  team
eviews  all  new  episodes  and  sends  queries  to  the  facilitator
f  it  finds  any  inconsistencies.
NeoKissEs  automatically  calculates  statistics,  including
he  incidence  density  of  BSI  per  1000  patient  days,  the  rate
f  catheter-associated  bloodstream  infection  (CABSI)  and
he  frequency  of  use  of  interventions  such  as  catheterization
nd  antibiotherapy.
ata  processing  and  dissemination
here  are  two  ways  in  which  data  are  analysed  and  feedback
rovided  to  participating  NICUs.  First,  for  each  NICU,  the
nline  system  can  generate  real-time  statistical  reports  of
utcomes  on  demand,  overall  and  by  birth  weight  and  ges-
ational  age  subsets.  In  addition,  when  the  data  for  every
ase  included  in  a  calendar  year  is  complete,  the  coordi-
ation  team  produces  an  annual  report.  This  report  offers
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Figure  2  Location  of  the  neonatal  intensive  care  units  (NI
more  detailed  information  adjusted  for  birth  weight,  gesta-
tional  age  and  level  of  care,  and  excludes  data  from  VLBW
infants  who  were  transferred,  discharged  or  deceased  within
72  hours  of  NICU  admission.  It  provides  a  detailed  account  of
surveillance  indicators  for  each  NICU  as  well  as  two  bench-
marking  summaries:  one  based  on  the  values  observed  in
the  Spanish  reference  population  of  NeoKissEs,  and  another
based  on  the  overall  statistics  for  the  same  year  in  the  Ger-
man  NEO-KISS  population.
Results
The  implementation  of  NeoKissEs  started  with  the  collabora-
tion  of  professionals  from  50  NICUs  from  15  administrative
regions  in  Spain  (Figure  2).  Eight  workshops  were  held  to
train  implementation  teams  on  the  management  of  the  sys-
tem  and  attended  by  a  total  of  210  health  professionals
(neonatologists  and  nurses).
The  45  units  that  ultimately  started  the  local  implemen-
tation  process  received  a  questionnaire  asking  about  the
details  of  the  implementation,  the  perceived  barriers  and
the  strategies  used  to  address  them.  The  survey  response
rate  was  71.1%  (32  units).  The  strategies  used  to  inform
the  staff  were:  1)  informative  meetings  for  the  entire  NICU
staff;  2)  series  of  specific  meetings  for  each  type  of  pro-
fessional  on  staff;  and  3)  meetings  attended  only  by  staff
that  expressed  an  interest  in  participating  in  the  initiative.
Twelve  champion  stated  that  in  spite  of  their  efforts  to
inform  and  motivate  their  colleagues,  they  ended  up  being
the  only  staff  directly  involved  in  data  collection  and  qual-
ity  assurance.  The  problems  reported  most  frequently  by
facilitators  as  having  a  negative  impact  on  the  implementa-
tion  were:  difficulty  in  establishing  the  NeoKissEs  team  due
to  lack  of  motivation  among  the  staff,  difficulty  ensuring
knowledge  of  the  initiative  by  all  NICU  staff,  a  high  turnover
rate  in  the  NICU,  especially  among  nurses,  and  poor  collab-





participating  in  the  NeoKissEs  surveillance  system  in  Spain.
Several  facilitators  felt  that  the  work  of  nurses  in  data
ollection  for  NeoKissEs  would  benefit  from  the  support  of
rofessionals  from  outside  the  unit  experienced  in  infec-
ion  prevention  and  control,  yet  only  two  NICUs  reported  an
ngoing  involvement  of  preventive  medicine  colleagues  in
nfection  assessment  and  control  in  close  cooperation  with
he  nurse  and  neonatologist.  This  collaboration  was  greatly
alued  in  both  instances.
By  the  beginning  of  2015,  the  NeoKissEs  website  was
ully  operational,  allowing  for  direct  data  entry  and  host-
ng  a  collection  of  streaming  video  tutorials  developed  to
esolve  possible  questions  concerning  the  correct  registra-
ion  of  cases  and  BSI  episodes  and  to  explain  how  to  produce
eports.  The  data  recorded  to  that  point  were  transferred
o  definitive  electronic  case  report  forms.
Real-time  statistical  reports  could  be  obtained  through
he  website  to  provide  feedback  to  the  champion.  These
eports  offered:  1)  general  patient  information,  such  as
ates  of  admission,  birth  weights,  etc,  2)  statistics  for  their
articular  unit  (rates  of  infection  and  device  use)  and  3)
omparative  analyses  of  their  NICU  and  other  units  based  on
he  summary  statistics  calculated  by  the  system.
Participating  NICUs  gradually  started  to  recruit  patients,
epending  on  the  date  that  the  facilitators  attended  the
raining  and  the  time  required  to  set  up  and  launch  the  sys-
em  in  their  hospitals  (Figure  3).  Of  the  50  NICUs  that  initially
oined  the  system,  45  had  registered  cases  by  December  31,
015  (Figure  1).  NeoKissEs  continues  to  gather  data  at  the
ime  of  this  writing.  All  participating  NICUs  were  classified
s  level  III  based  on  the  level  of  care  they  offered:  Level  III-A
15  NICUs,  660  infants),  level  III-B  (23  NICUs,  1863  infants)
nd  level  III-C  (7  NICUs,  1115  infants).14
During  the  pilot  phase,  the  two  participating  NICUs
ncluded  260  VLBW  infants  that  were  monitored  for  a  total
f  9324  days;  of  these  infants,  81  (31.2%)  developed  CAB-
Is,  with  an  overall  incidence  rate  of  19.6  CABSIs  per  1000
atheter-days  (95%  CI,  15.5-24.0).  From  the  time  that  NICU
ecruitment  started  nationwide  (February  8,  2013)  through
8  M.  Madrid-Aguilar  et  al.










































































Figure  3  Follow-up  period  in  the  NeoKissEs  su
he  end  of  2015,  3750  infants  were  registered  in  the  system,
f  who  112  (3.0%)  were  excluded  from  the  analysis  because
hey  did  not  meet  the  inclusion  criteria.
Table  1  summarises  the  perinatal  characteristics  of  the
638  infants  that  met  the  inclusion  criteria.  Overall,  966
LBW  infants  (26.6%)  had  at  least  one  episode  of  BSI  during
he  followup  in  the  system.  Compared  to  VLBW  infants  with-
ut  BSI,  those  with  BSI  had  been  born  at  lower  gestational
ges  with  lower  birth  weights  and  had  a  higher  mortality
uring  the  surveillance  period  (relative  risk,  1.8;  95%  CI,
.4-2.3).  Furthermore,  the  device  use  rates  (for  vascular
atheters  and  antibiotics)  and  length  of  stay  recorded  in  the
ystem  were  higher  in  this  group  (Table  1).
A  total  of  1108  episodes  of  CABSI  were  registered,  corre-
ponding  to  an  incidence  rate  of  18.4  BSIs  per  1000  catheter
ays  (95%  CI,  17.8-19.1).  We  found  considerable  variability
n  the  CABSI  rate  between  the  45  NICUs  that  registered  cases
uring  the  study  period  (Figure  4).  In  the  analysis  by  level  of
are,  CABSI  rates  ranged  from  4.7  to  34.9  in  class  III-A  units,
rom  3.9  to  29.0  in  class  III-B  units,  and  from  18.6  to  34.0  in
lass  III-C  units.
iscussion
ur  results  reflect  the  successful  implementation  in  a  sub-
tantial  number  of  Spanish  NICUs  of  the  German  system
NEO-KISS)  validated  for  the  surveillance  of  nosocomial  BSIs
n  the  VLBW  infant  population.  Our  study  also  produced
nitial  data  on  standardised  indicators  (statistics  on  BSI,
ABSI,  and  antibiotic  and  device  use)  and  identify  signifi-
ant  challenges  and  barriers  that  need  to  be  addressed  in  the
mplementation  and  management  of  the  surveillance  system





lance  system  by  administrative  region  in  Spain.
Previous  research  has  shown  that  the  implementation
f  a  BSI  surveillance  system  specifically  focused  on  VLBW
nfants  may  help  reduce  the  impact  of  sepsis  in  NICUs.4
his  positive  effect  may  be  due  to  the  systematic  collec-
ion  of  data  through  specific  methods  and  the  application
f  standardised  definitions  that  facilitate  the  analysis  and
nterpretation  of  statistics,  the  comparison  between  NICUs
nd  feedback  to  clinicians.4,10,18
Our  experience  demonstrates  that  it  is  possible  to  adapt
nd  implement  a  prospective  surveillance  system  for  BSI  in
he  population  of  VLBW  infants  admitted  to  Spanish  NICUs.
ith  its  standardised  procedures  and  outcomes,  NeoKissEs
ay  well  become  the  Spanish  reference  system  for  the  col-
ection  and  use  of  BSI  data  in  VLBW  infants  for  benchmarking
nd  quality  improvement  purposes.  The  data  from  NeoKissEs
upplements  the  information  produced  since  1994  by  the
eonatal  Network  of  the  Castrillo  Hospital  Group  in  Spain,19
hose  data  collection  is  restricted  to  microbiologically-
onfirmed  cases  of  neonatal  BSI,  but  periodically  provides
seful  reports  on  the  antibiotic  susceptibility  of  the  isolated
icroorganisms.  Our  initial  cumulative  incidence  (26.6%)
as  only  slightly  higher  than  the  one  described  by  the
astrillo  Group  (21.3%)  (Fernández-Colomer  B,  Coto-Cotallo
.D.  27  October  2017,  unpublished  raw  data)  and  in  early
eports  of  the  German  NEO-KISS  system  (21.3%).5 On  the
ther  hand,  the  BSI  incidence  rate  per  1000  patient  days
nd  CABSI  rate  per  1000  catheter  days  found  by  NeoKissEs
re  much  higher  compared  to  the  earliest  benchmarking
ataset  obtained  from  the  German  system  (9.2  vs  6.5  and
8.4  vs  9.2,  respectively).5 This  gap  was  even  larger  when
e  compared  our  data  to  the  NEO-KISS  values  for  theame  time  period  (2013-2015)  (3.8  BSI  episodes  per  1000
atient  days  and  6.5  CABSI  episodes  per  1000  catheter
ays)  (Piening  B,  24  November  2017,  unpublished  raw  data),
hich  highlights  the  role  of  NeoKissEs  as  a  useful  tool
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Table  1  Perinatal  characteristics,  mortality  and  device  use  in  patients  that  did  and  did  not  develop  bloodstream  infections
(implementation  phase).
Parameter  All  infants  No  BSI  BSI  P
Patient  characteristics
Patients,  n  3638  2672  966
Total patient  daysa 131  485  85  420  46  065
Length of  stay  (days)a Median  (IQR)  32.5  (23-46)  29  (21-40)  45  (31-63)  <  .001d
Birth  weight  (g)  Mean  (SD) 1116.6  (273.9)  1176.2  (254.0)  951.5  (259.0)  <  .001d
<  1000  g,  n  (%) 1225  (33.7) 664  (24.9) 561  (58.1) <  .001e
Gestational  age  (weeks)Median  (IQR) 29  (27-31) 30  (28-32) 27  (26-29) <  .001d
<  28  weeks,  n  (%) 1457  (40.0) 832  (31.1) 625  (64.7) <  .001e
CRIB  scoreb,  Median  (IQR)  1  (1-4)  1  (0-2)  2.5  (1-5)  <  .001d
Sex  (male),  n  (%)  1823  (50.1)  1313  (49.1)  510  (52.8)  .051e
Delivery  (caesarean),  n  (%)  2697  (74.2)  1994  (74.6)  703  (72.8)  .260e
Multiple  birth,  n  (%)  1282  (35.2)  959  (35.9)  323  (33.4)  .171e
Mortality,  n  (%) 274  (7.5) 166  (6.2) 108  (11.2) <  .001e
Rate  of  vascular  catheter/antibiotic  usec
Vascular  catheter,  Median  (IQR)  40.0  (26.1-64.5)  33.3  (22.9-51.4)  64.1  (46.3-91.7)  <  .001d
Antibiotic  use  Median  (IQR)  21.1  (7.7-42.3)  14.5  (0.0-28.5)  44.2  (30.8-64.0)  <  .001d
Abbreviations: BSI, bloodstream infection; CRIB, Clinical Risk Index for Babies; IQR, interquartile range; SD, standard deviation.
a Until the end of the surveillance; b Score calculated in 2466 patients; c Number of catheter and/or antibiotic days per 100 patient
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Figure  4  Catheter-associated  bloodstream  infection  (CABSI)  
of care.
to  stimulate  research  on  potentially  modifiable  risk  fac-
tors.
Our  preliminary  findings  also  brought  to  light  other  issues
that  need  considering.  First  of  all,  we  found  consider-
able  heterogeneity  in  the  approaches  used  to  implement
the  surveillance  system  at  each  site,  despite  the  general
consensus  achieved  in  the  implementation  workshops.  Some
NICUs  reported  difficulties  forming  multidisciplinary  teams
to  direct  the  implementation  process,  ending  with  a sin-
gle  person  being  responsible  for  all  data  collection  activities




 in  participating  neonatal  intensive  care  units  (NICUs)  by  level
evel.  Further,  accurate  measurement  and  reporting  is  of
ritical  importance  but  of  limited  effect  if  not  accompanied
y  organised  efforts  to  address  the  main  factors  associated
ith  an  increased  risk  of  BSI.  The  reported  difficulties  in
aintaining  stable  implementation  teams  could  be  a  major
arrier  to  these  units  benefitting  from  benchmarking  infor-
ation  to  drive  the  design  and  implementation  of  better
20ractices.
Secondly,  the  responses  to  the  survey  showed  that  there
as  substantial  variability  in  the  resources  available  in  the




































































































taffing,  levels  of  motivation,  reward  systems  and  quality
ssurance  policies.  All  these  factors  should  be  taken  into
ccount  in  the  near  future,  when,  as  we  hope,  NeoKissEs
ecomes  the  national  framework  for  the  introduction  and
valuation  of  evidence-based  best  practices  and  quality
mprovement  initiatives  focused  on  the  prevention  and  con-
rol  of  BSI  in  VLBW  infants.
Thirdly,  the  huge  variability  observed  so  far  in  the  fre-
uency  of  BSI  episodes,  even  in  NICUs  with  the  same  level  of
are  (Figure  4),  suggests  the  existence  of  potentially  mod-
fiable  health  care-related  factors.  This  calls  for  in-depth
xamination  of  these  factors  and  the  development  of  an
ppropriate  framework  for  targeted  actions  aimed  at  reduc-
ng  the  rates  of  preventable  infection  in  the  future.  Many
eoKissEs  units  are  currently  participating  in  a  new  inter-
entional  study  to  test  the  systematic  implementation  of
 set  of  bundles  of  measures  concerning  the  insertion  and
aintenance  of  central  vascular  catheters  in  VLBW  infants
ith  the  aim  of  reducing  CABSI  rates.  NeoKissEs  will  con-
inue  to  support  the  collection  of  BSI  statistics  for  these
nits  and  will  be  used  to  assess  the  impact  of  the  bundle
nterventions.
The  creation  of  a  web-based  electronic  support  sys-
em  has  greatly  facilitated  the  consecutive  registration  of
atients  and  BSI  episodes  and  the  monitoring  of  data  qual-
ty.  It  allows  NICUs  to  consult  their  statistics,  for  their
wn  unit  or  in  comparison  with  others,  at  any  time.  It
lso  helps  identify  areas  for  improvement  by  comparing
heir  results  with  the  overall  data  provided  by  NeoKissEs
nd  the  data  from  the  German  NEO-KISS.  Comparisons  may
e  biased  if  there  is  heterogeneity  in  the  compared  pop-
lations  (case  mix  bias).21 To  address  this,  the  system
arries  out  adjusted  analyses,  providing  comparisons  that
re  more  valid  by  taking  into  account  factors  such  as  birth
eight,  gestational  age  and  the  complexity  of  the  provided
are.
The  number  of  NICUs  that  participate  in  NeoKissEs
nsures  a  sufficiently  large  sample  of  individuals  and  BSI
pisodes  to  provide  accurate  and  reliable  statistics  and
acilitate  the  performance  of  studies  of  appropriate  scope
o  evaluate  the  safety  and  effectiveness  of  specific  inter-
entions  and  policies.  That  said,  expanding  the  NeoKissEs
ystem  would  make  the  data  more  representative  of  the
hole  of  Spain.  There  is  the  limitation  that  NeoKissEs  was
eveloped  in  the  framework  of  a  research  project  funded
or  a  limited  period  of  time  and  that  it  has  yet  to  be
ermanently  integrated  into  the  Spanish  National  Health
ystem,  unlike  NEO-KISS,  in  which  participation  has  been
andatory  for  all  German  neonatal  units  since  2006.  It
ould  also  be  advisable  for  NeoKissEs  to  establish  col-
aborations  with  other  similar  initiatives,  registries  and
eonatal  networks  to  share  data,  expand  benchmarking
ctivities  and  encourage  the  systematic  analysis  of  the  risks
ssociated  with  the  development  of  BSI  in  this  popula-
ion.
onclusionseoKissEs  has  been  implemented  in  45  Spanish  NICUs  and
as  proven  to  be  a  useful  source  of  information  on  the
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tandardised  system  is  easy  to  use  and  widely  accepted  by
sers,  and  provides  standardised  definitions,  procedures
nd  data  collection  instruments  that  allow  comparative
ssessments.  We  believe  that  this  system  would  be  a  good
ool  for  evaluating  ongoing  interventions  aimed  at  improv-
ng  health  care  quality  and  to  promote  the  implementation
f  safe  practices  in  participating  NICUs,  individually  or  as  a
roup.  It  would  no  doubt  benefit  from  being  used  by  a  larger
umber  of  NICUs,  greater  integration  in  the  daily  activity
f  health  care  staff  and  sustained  institutional  support.
tatements
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he  NeoKissEs  protocol  was  first  assessed  and  approved
y  the  Basque  Country  Clinical  Research  Ethics  Commit-
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valuated  and  approved  by  the  regional  and  local  ethics
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equirement  of  written  individual  informed  consent  was
aived  due  to  the  nature  of  the  research  and  the  use  of
nonymised  data.
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